Business

Can Procter & Gamble Hit New Highs When It Reports Thursday Morning?

Procter & Gamble Co. (NYSE: PG) is set to report its fiscal second-quarter financial results after the closing bell on Wednesday. The consensus estimates are calling for $1.37 in earnings ...
Read Full Story »

Is Express Bucking the Trend of Struggling Retailers?

Amid the pullbacks that retailers have experienced in and following this holiday season, there seems to be at least one retailer that made actual progress. We already have seen sales ...
Read Full Story »

Why 2020 May Be the Year for Organigram Stock

It's a little awkward talking about cannabis companies after a horrible, bad, not-very-good year like 2019. The industry's largest exchange-traded fund, the ETFMG Alternative Harvest ETF (NYSEARCA: MJ), ended the ...
Read Full Story »

Boeing Moves the Goal Posts on 737 Max Flight Resumptions

In a statement late Tuesday, Boeing Co. (NYSE: BA) revised yet again its estimate of when the grounded 737 Max aircraft will receive regulatory approval to fly again. The company ...
Read Full Story »

Why This Cardiovascular Disease Study Could Be Huge

Akcea Therapeutics Inc. (NASDAQ: AKCA) and Ionis Pharmaceuticals Inc. (NASDAQ: IONS) each made handy gains on Wednesday after they reported midstage results for their cardiovascular disease study. Specifically, the results ...
Read Full Story »

Some Great News for Potential Alzheimer’s Treatment

It may be unusual to see a stock rise close to 100% without a corporate buyout, but in biotech and emerging pharmaceutical companies gains of that size can occur simply ...
Read Full Story »

Why Johnson & Johnson Stock Is Not Reacting More Positively to Earnings

Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2019 results before markets opened Wednesday. The health care giant reported quarterly adjusted diluted earnings per share (EPS) of $1.88 on revenue of ...
Read Full Story »

Is This Bottom Line Beat Enough for Netflix Investors?

Netflix Inc. (NASDAQ: NFLX) reported its most recent quarterly results after markets closed Tuesday. The firm said that it had $1.30 in earnings per share (EPS) and $5.47 billion in ...
Read Full Story »

China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks

China is facing an outbreak of the coronavirus, which may have spread to a few other countries in East Asia. Although less than 300 infections have been reported, there are ...
Read Full Story »

How Badly Will Disney Hurt Netflix Earnings?

Netflix Inc. (NASDAQ: NFLX) is scheduled to release its fourth-quarter financial results after the markets close on Tuesday. The consensus estimates call for $0.53 in earnings per share (EPS) and ...
Read Full Story »

FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock

When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. ...
Read Full Story »

Winning Ideas in Biotech/Pharma After JPMorgan Healthcare Conference

For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past week. In fact, brokerage firm Janney spent last week visiting ...
Read Full Story »

Americans Don’t Want to Drive Electric Cars

The drive toward fleets of all-electric cars has cost major manufacturers billions of dollars and will cost billions more. There is no international car company that is not part of ...
Read Full Story »

Why $2 Billion Impairment Charge Isn’t Hurting Halliburton Stock

Halliburton Co. (NYSE: HAL) reported fourth-quarter 2019 results before markets opened Tuesday. For the quarter, the oil and gas services company posted adjusted diluted earnings per share (EPS) of $0.32 ...
Read Full Story »

Tesla Sold Over 40,000 Cars In China Last Year

As car manufacturers struggle with the downturn in China's car sales, and some large car makers posted double-digit declines last year, Tesla's sales have surged and rose to over 40,000 ...
Read Full Story »